Aphena Pharma Solutions Seeks DEA Registration for Methamphetamine Import
March 06, 2025
March 06, 2025
WASHINGTON, March 6 (TNSFR) -- Aphena Pharma Solutions MD, LLC has submitted an application to the Drug Enforcement Administration (DEA) seeking registration as an importer of methamphetamine, a Schedule II controlled substance.
The company, located in Easton, Maryland, intends to import the drug exclusively for internal use in the manufacturing of an FDA-approved over-the-counter (OTC) product. The DEA's review process will ensure the proposed importation aligns with legal an . . .
The company, located in Easton, Maryland, intends to import the drug exclusively for internal use in the manufacturing of an FDA-approved over-the-counter (OTC) product. The DEA's review process will ensure the proposed importation aligns with legal an . . .